LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1HRV Pharma
03 1Maithri Drugs
04 1Lupin Manufacturing Solutions
05 1Acura Labs
06 1Apicore
07 1Arene Lifesciences
08 1Aspire Lifesciences Pvt Ltd
09 1Aurobindo Pharma Limited
10 1Aurore Life Sciences
11 1Chromo Laboratories
12 1Corey Organics
13 2Divis Laboratories
14 1Emcure Pharmaceuticals
15 3Hetero Drugs
16 1Laurus Labs
17 2Lupin Ltd
18 1MSN Laboratories
19 1Mana Pharma SL
20 1Merck & Co
21 1Prajna Generics
22 1SGMR Pharmaceuticals
23 1Saintsun Pharma
24 1Shanghai Desano Chemical Pharmaceutical Co., Ltd.
25 1Shenzhen Oriental Pharmaceutical
26 1Siegfried AG
27 1Teva Pharmaceutical Industries
28 1Tianish Laboratories
29 2Viatris
30 1Viwit Pharmaceuticals Limited
31 1Blank
Reset all filters
01 4China
02 24India
03 1Israel
04 1Spain
05 1Switzerland
06 4U.S.A
07 1Blank
Reset all filters
01 7Active
02 2Inactive
03 27Blank
01 4Valid
02 32Blank
Reset all filters
01 36Blank
Reset all filters
01 1WC-0030
02 1WC-0040
03 1WC-0118
04 1WC-0407
05 1WC-0436
06 1WC-0459
07 1WC-0487
08 29Blank
Reset all filters
01 1906-5-ND
02 1Su90-20-ND
03 1Su90-21-ND
04 1Su906-10-ND
05 32Blank
Reset all filters
01 117381-749
02 159651-924
03 162331-055
04 165015-841
05 165977-0049
06 165977-0129
07 165977-0158
08 170600-028
09 28Blank
01 36Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36083
Submission : 2021-06-30
Status : Active
Type : II
Date of Issue : 2024-02-12
Valid Till : 2027-02-11
Written Confirmation Number : WC-0407
Address of the Firm :
| Available Reg Filing : ASMF, BR |
Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-08-25
DMF Number : 34206
Submission : 2019-09-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25261
Submission : 2011-09-06
Status : Active
Type : II
Certificate Number : CEP 2023-193 - Rev 00
Issue Date : 2025-07-28
Type : Chemical
Substance Number : 2887
Status : Valid
Date of Issue : 2025-09-19
Valid Till : 2028-07-03
Written Confirmation Number : WC-0040
Address of the Firm :
NDC Package Code : 65977-0129
Start Marketing Date : 2007-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-08
Pay. Date : 2023-01-10
DMF Number : 37182
Submission : 2022-12-10
Status : Active
Type : II
NDC Package Code : 65977-0158
Start Marketing Date : 2007-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2013-12-09
DMF Number : 27728
Submission : 2013-12-24
Status : Active
Type : II
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-02
Pay. Date : 2016-06-21
DMF Number : 30595
Submission : 2016-06-24
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25753
Submission : 2012-04-02
Status : Inactive
Type : II
Date of Issue : 2025-02-20
Valid Till : 2028-01-28
Written Confirmation Number : WC-0436
Address of the Firm :

10
PharmaCompass offers a list of Raltegravir Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Raltegravir Potassium manufacturer or Raltegravir Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Raltegravir Potassium manufacturer or Raltegravir Potassium supplier.
PharmaCompass also assists you with knowing the Raltegravir Potassium API Price utilized in the formulation of products. Raltegravir Potassium API Price is not always fixed or binding as the Raltegravir Potassium Price is obtained through a variety of data sources. The Raltegravir Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Raltegravir Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raltegravir Potassium, including repackagers and relabelers. The FDA regulates Raltegravir Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raltegravir Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Raltegravir Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Raltegravir Potassium supplier is an individual or a company that provides Raltegravir Potassium active pharmaceutical ingredient (API) or Raltegravir Potassium finished formulations upon request. The Raltegravir Potassium suppliers may include Raltegravir Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Raltegravir Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 30 companies offering Raltegravir Potassium
Get in contact with the supplier of your choice: